Harano M - Search Results

1

Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.

Eto M, Kamiryo Y, Takeuchi A, Harano M, Tatsugami K, Harada M, Kiyoshima K, Hamaguchi M, Teshima T, Tsuneyoshi M, Yoshikai Y, Naito S. Eto M, et al. Among authors: harano m. Clin Cancer Res. 2008 May 1;14(9):2833-40. doi: 10.1158/1078-0432.CCR-07-1742. Clin Cancer Res. 2008. PMID: 18451251

2

Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice.

Harano M, Eto M, Iwai T, Tatsugami K, Kiyoshima K, Kamiryo Y, Tsuneyoshi M, Yoshikai Y, Naito S. Harano M, et al. Cancer Res. 2005 Nov 1;65(21):10032-40. doi: 10.1158/0008-5472.CAN-05-0457. Cancer Res. 2005. PMID: 16267029

3

Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host disease.

Eto M, Harano M, Tatsugami K, Harada M, Kamiryo Y, Kiyoshima K, Hamaguchi M, Tsuneyoshi M, Yoshikai Y, Naito S. Eto M, et al. Among authors: harano m. Clin Cancer Res. 2007 Feb 1;13(3):1029-35. doi: 10.1158/1078-0432.CCR-06-1578. Clin Cancer Res. 2007. PMID: 17289899

4

Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma.

Tatsugami K, Eto M, Harano M, Hamaguchi M, Miyamoto T, Morisaki T, Furue M, Akashi K, Naito S. Tatsugami K, et al. Among authors: harano m. Int J Urol. 2008 Aug;15(8):694-8. doi: 10.1111/j.1442-2042.2008.02088.x. Epub 2008 Jun 16. Int J Urol. 2008. PMID: 18564205

5

Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantation.

Hamaguchi M, Eto M, Kamiryo Y, Takeuchi A, Harano M, Tatsugami K, Teshima T, Harada M, Yoshikai Y, Naito S. Hamaguchi M, et al. Among authors: harano m. Cancer Sci. 2009 Jan;100(1):138-43. doi: 10.1111/j.1349-7006.2008.01014.x. Epub 2008 Nov 24. Cancer Sci. 2009. PMID: 19037994 Free PMC article.

6

Donor CD4 T cells are critical in allogeneic stem cell transplantation against murine solid tumor.

Kamiryo Y, Eto M, Yamada H, Yajima T, Harano M, Takeuchi A, Tatsugami K, Hamaguchi M, Naito S, Yoshikai Y. Kamiryo Y, et al. Among authors: harano m. Cancer Res. 2009 Jun 15;69(12):5151-8. doi: 10.1158/0008-5472.CAN-08-2517. Epub 2009 Jun 2. Cancer Res. 2009. PMID: 19491277

7

Dendritic-cell therapy after non-myeloablative stem-cell transplantation for renal-cell carcinoma.

Tatsugami K, Eto M, Harano M, Nagafuji K, Omoto K, Katano M, Harada M, Naito S. Tatsugami K, et al. Among authors: harano m. Lancet Oncol. 2004 Dec;5(12):750-2. doi: 10.1016/S1470-2045(04)01652-3. Lancet Oncol. 2004. PMID: 15581547 No abstract available.

8

Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinoma.

Eto M, Harada M, Tatsugami K, Harano M, Koga H, Matsuzaki G, Naito S. Eto M, et al. Among authors: harano m. BJU Int. 2005 Feb;95(3):421-4. doi: 10.1111/j.1464-410X.2005.05313.x. BJU Int. 2005. PMID: 15679807

9

Long-term outcome of hand-assisted laparoscopic radical nephrectomy for localized stage T1/T2 renal-cell carcinoma.

Harano M, Eto M, Omoto K, Tatsugami K, Nomura H, Koga H, Hojyo M, Yamaguchi A, Naito S. Harano M, et al. J Endourol. 2005 Sep;19(7):803-7. doi: 10.1089/end.2005.19.803. J Endourol. 2005. PMID: 16190832

10

[Therapeutic indication of interferons for renal cell carcinoma].

Harano M, Naito S. Harano M, et al. Nihon Rinsho. 2006 Feb;64 Suppl 2:647-51. Nihon Rinsho. 2006. PMID: 16523970 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters